论文部分内容阅读
过去十多年,中国动物疫苗行业呈现快速发展态势,市场规模以18%的复合增速前进,截至2013年中国动物疫苗市场规模已接近110亿元,猪用疫苗更是占据着动物疫苗很大的市场份额。就在刚过去的2014年,国内猪用疫苗市场表现依然强劲,仅新上市的猪圆环病毒疫苗就有天邦、永顺、易邦、中博四家,而此前已上市的猪圆环病毒疫苗已有勃林格、南农高科、哈维科、海利、瑞普、福州大北农、普莱柯、武汉科前、梅里亚等九家之多,同种类型疫苗的集中获批和上市,必将引发疫苗市场的价格大战。
In the past 10 years or so, the animal vaccines industry in China showed a rapid development trend with a market of 18% compound growth rate. As of 2013, the animal vaccines market in China is close to 11 billion yuan, and the swine vaccines occupy a large area of animal vaccines Market share. Just in 2014, the performance of the domestic pig vaccine market remains strong. Only newly listed porcine circovirus vaccines include Tianbang, Yongshun, YiBang and ZhongBo, and the previously listed porcine circovirus Vaccines have been Boehringer, Nannong Tech, Harvard, Haili, Rip, Fuzhou Dabei Nong, Pulaike, Wuhan Branch, Meria and many more, the same type of vaccine was approved And listed, will trigger the vaccine market price war.